Matthew Buckland | International and Private Care

Dr Buckland is an immunologist with a special interest in diagnostics for rare disorders and the management of children and young adults with primary immunodeficiencies.

Dr Buckland leads the UK registry for Primary Immunodeficiency (PID) and is the Medical Chair of the leading national support organisation in the UK, PIDUK.

Immunodeficiency
Autoimmunity

MBBS
BSc
MSc
PhD
FRCP
FRCPath
DipHIVMed
PGCAP
FHEA

Immune regulation
Transplantation tolerance

المنشورات والمقالات

Duraisingham, S. S., Manson, A., Grigoriadou, S., Buckland, M., Tong, C. Y. W., & Longhurst, H. J. 2015. Immune deficiency: changing spectrum of pathogens.. Clin Exp Immunol, 181(2) pp. 267-274.

Duraisingham, S. S., Hanson, S., Buckland, M., Grigoriadou, S., & Longhurst, H. J. 2014. Pseudomonas infection in antibody deficient patients.. Eur J Microbiol Immunol (Bp), 4(4) pp. 198-203.

Duraisingham, S. S., Buckland, M.S., Grigoriadou, S., & Longhurst, H. J. 2014. Secondary antibody deficiency. Expert Rev Clin Immunol. 10(5) pp.583-591.

Tohani, A., Chua, I., Grigoriadou, S., Buckland, M.S., & Longhurst, H. J. 2014. Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency? Ann Allergy Asthma Immunol.112(3) pp. 265-267.

Manson, A. L., Dempster, J., Grigoriadou, S., Buckland, M.S., & Longhurst, H. J. 2014. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema. Eur J Dermatol. 24(1) pp. 28-34.

Edgar, J.D.M., Buckland,M., Guzman, D., Conlon, N. P., Knerr, V., Bangs, C., . . . Slatter, M. 2014. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol. 175(1) pp. 68-78.

Duraisingham, S. S., Buckland, M., Dempster, J., Lorenzo, L., Grigoriadou, S., & Longhurst, H. J. 2014. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.. PLoS One. 9(6), e100324.

Dorling, A., Rebollo-Mesa, I., Hilton, R., Peacock, J. L., Vaughan, R., Gardner, L., . . . Murphy, C. 2014. Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trials.15, 30.

Smyth, L. A., Ratnasothy, K., Moreau, A., Alcock, S., Sagoo, P., Meader, L., . . . Lombardi, G. 2013. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.. J Immunol, 190(9), pp. 4848-4860. Duraisingham, S. S., Manson, A., Grigoriadou, S., Buckland, M., Tong, C. Y. W., & Longhurst, H. J. 2015. Immune deficiency: changing spectrum of pathogens. Clin Exp Immunol. 181(2) pp. 267-274.

Duraisingham, S. S., Hanson, S., Buckland, M., Grigoriadou, S., & Longhurst, H. J. 2014. Pseudomonas infection in antibody deficient patients.Eur J Microbiol Immunol (Bp). 4(4) pp. 198-203.

Duraisingham, S.S., Buckland, M.S., Grigoriadou, S., & Longhurst, H.J. 2014. Secondary antibody deficiency. Expert Rev Clin Immunol.10(5) pp.583-591.

Tohani, A., Chua, I., Grigoriadou, S., Buckland, M.S., & Longhurst, H.J. 2014. Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?. Ann Allergy Asthma Immunol, 112(3) pp. 265-267.